{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1021.11","meta":{"versionId":"13","lastUpdated":"2016-03-31T01:00:12.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.11","version":"20160331","name":"Injectable factor Xa inhibitor for VTE prophylaxis ingredient specific","status":"active","date":"2016-03-31T01:00:12-04:00","publisher":"TJC EH Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"321208","display":"fondaparinux"}]}]},"expansion":{"identifier":"urn:uuid:d7aafc83-9f04-4d98-b344-e46a5c48b835","timestamp":"2022-06-10T08:51:09-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"321208","display":"fondaparinux"}]}}